Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04002297
Title Study Comparing Zanubrutinib + Rituximab Versus Bendamustine + Rituximab in Patients With Untreated Mantle Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors BeiGene
Indications
Therapies
Age Groups: senior
Covered Countries

Facility Status City State Zip Country Details
National Hospital Organization Nagoya Medical Center Nagoyashi Aichi 460-0001 Japan Details
Toyohashi Municipal Hospital Toyohashi Aichi 441-8570 Japan Details
Chiba Cancer Center Chibashi Chiba 260-8717 Japan Details
Kurume University Hospital Kurume Fukuoka 830-0011 Japan Details
Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital Hiroshimashi Hiroshima 730-8619 Japan Details
Kanagawa Cancer Center Yokohamashi Kanagawa 241-8515 Japan Details
Yokohama Municipal Citizens Hospital Yokohama Kanagawa 2408555 Japan Details
National Hospital Organization Kumamoto Medical Center Kumamotoshi Kumamoto 860-0008 Japan Details
Tohoku University Hospital Sendaishi Miyagi 980-8574 Japan Details
Kurashiki Central Hospital Kurashikishi Okayama 710-8602 Japan Details
Osaka Red Cross Hospital Osakashi Osaka 543-8555 Japan Details
National Cancer Center Hospital Chuoku Tokyo 104-0045 Japan Details
University Hospital, Kyoto Prefectural Univ of Medicine Kyoto 602-8566 Japan Details
National Hospital Organization Okayama Medical Center Okayama 701-1192 Japan Details
Osaka Metropolitan University Hospital Osaka 545-8586 Japan Details
Tokyo Medical and Dental University Hospital Tokyo 113-8519 Japan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field